Peter Bjerre Toft

Peter Bjerre Toft serves as a Clinical Associate Professor at the Department of Clinical Medicine, University of Copenhagen, with clinical specialization in Ophthalmology. His institutional affiliation is centered at Blegdamsvej 3, 2200 Copenhagen N, operating within Denmark's integrated university-hospital system (Region Hovedstaden). With 63 documented research outputs including journal articles, reviews, and book chapters, his work bridges clinical practice and academic research in ocular pathology.

Dr. Toft's research program focuses on three core domains: (1) thyroid eye disease epidemiology using Danish nationwide registries, (2) orbital and lacrimal system tumors with emphasis on molecular drivers, and (3) strabismus surgery optimization in Graves' orbitopathy. His methodology frequently leverages Denmark's unique health registry infrastructure for longitudinal cohort studies while maintaining clinical relevance through surgical technique evaluations and rare case documentation. Recent work demonstrates particular innovation in combining brachytherapy with cryotherapy for ocular surface tumors and investigating viral genomic factors in lacrimal drainage neoplasms.

Analysis of his 2021-2024 publications reveals consistent output in high-impact ophthalmology journals including Acta Ophthalmologica, JAMA Ophthalmology, and Cancers. His research shows strong collaborative patterns with Copenhagen University Hospital colleagues, particularly in multidisciplinary thyroid-ophthalmology studies. Notable attention includes social media dissemination (6 X users, 30 Mendeley readers) for his thyroid eye disease incidence study and news coverage of his lacrimal tumor genomic research.

Professional activities include authorship of textbook chapters for Oculoplastic, Lacrimal and Orbital Surgery (Springer) and regular contributions to clinical guidelines through the European Society of Ophthalmic Plastic and Reconstructive Surgery (ESOPRS). His clinical work directly informs research priorities, particularly in optimizing anesthesia protocols for strabismus surgery and characterizing rare pediatric ocular adnexal tumors.